期刊文献+

表达O型口蹄疫病毒衣壳蛋白的重组腺病毒构建及其免疫原性分析 被引量:4

Construction of recombinant adenovirus expressing capsid protein of serotype O foot-and-mouth disease virus and analysis of its immunogenicity
原文传递
导出
摘要 为构建表达O型口蹄疫病毒(foot-and-mouth disease virus, FMDV)衣壳蛋白的复制缺陷型人5型腺病毒(Ad5)为载体的重组腺病毒,本研究设计、合成特异性引物并扩增出FMDV-OZK93的P12A、3B3C基因,通过融合PCR方法连接2个片段,获得P12A3B3C基因后插入到pDC316-mCMV-EGFP质粒,构建了能够表达FMDV-OZK93株衣壳蛋白前体P12A和3B3C蛋白酶的重组穿梭质粒pDC316-mCMV-EGFP-P12A3B3C。利用AdMax^(TM)腺病毒包装系统进行重组腺病毒rAdv-P12A3B3C-OZK93的包装、鉴定及扩增;并感染人胚胎肾细胞HEK-293进行表达验证。将鉴定正确且高度纯化后的重组腺病毒肌肉免疫小鼠进行免疫原性分析。结果显示,rAdvP12A3B3C-OZK93在病毒传代过程中目的基因稳定存在,且病毒滴度可达1×10^(9.1)TCID_(50)/mL。间接免疫荧光和Western blotting结果均表明rAdv-P12A3B3C-OZK93在HEK-293细胞中表达了FMDV特异性蛋白P12A和VP1。PK细胞感染实验证明rAdv-P12A3B3C-OZK93可感染猪源细胞,这为构建的rAdv-P12A3B3C-OZK93用于猪对抗FMDV的免疫与保护奠定了基础。相比于FMDV灭活疫苗免疫的小鼠,重组腺病毒免疫小鼠后可诱导机体产生更高水平的FMDV特异性抗体以及γ-IFN和IL-10应答反应,表明该重组腺病毒可对动物机体产生良好的免疫原性,为后续研制新型口蹄疫活载体疫苗奠定了重要基础。 In order to construct a recombinant replication deficient human type 5 adenovirus(Ad5)expressing a foot-and-mouth disease virus(FMDV) capsid protein, specific primers for P12A and 3B3C genes of FMDV-OZK93 were synthesized. The P12A and 3B3C genes were then amplified and connected by fusion PCR, and a recombinant shuttle plasmid pDC316-mCMV-EGFP-P12A3B3C expressing the FMDV-OZK93 capsid protein precursor P12A and 3B3C protease were obtained by inserting the P12A3B3C gene into the pDC316-mCMV-EGFP plasmid. The recombinant adenovirus rAdv-P12A3B3C-OZK93 was subsequently packaged, characterized and amplified using AdMaxTM adenovirus packaging system, and the expression was verified by infecting human embryonic kidney cell HEK-293. The humoral and cellular immunity levels of well-expressed and purified recombinant adenovirus immunized mice were evaluated. The results showed that rAdv-P12A3B3C-OZK93 could be stably passaged and the maximum virus titer reached 1×10^(9.1)TCID_(50)/mL. Western blotting and indirect immunofluorescence showed that rAdv-P12A3B3C-OZK93 expressed the FMDV-specific proteins P12A and VP1 in HEK-293 cells. In addition, the PK cell infection experiment confirmed that rAdv-P12A3B3C-OZK93 could infect porcine cells, which is essential for vaccination in pigs.Comparing with the inactivated vaccine group, the recombinant adenovirus could induce higher FMDV-specific IgG antibodies, γ-IFN and IL-10. This indicates that the recombinant adenovirus has good immunity for animal, which is very important for the subsequent development of foot-and-mouth disease vaccine.
作者 王灿灿 张莉萍 刘新生 周鹏 潘丽 王永录 WANG Cancan;ZHANG Liping;LIU Xinsheng;ZHOU Peng;PAN Li;WANG Yonglu(OIE/National Foot-and-Mouth Disease Reference Laboratory,State Key Laboratory of Veterinary Etiological Biology,Lanzhou Veterinary Research Institute,Chinese Academy of Agricultural Sciences,Lanzhou 730046,Gansu,China)
出处 《生物工程学报》 CAS CSCD 北大核心 2022年第5期1824-1836,共13页 Chinese Journal of Biotechnology
关键词 O型口蹄疫病毒 重组腺病毒 P12A和3B3C 免疫原性 FMDV serotype O recombinant adenovirus P12A and 3B3C immunogenicity
  • 相关文献

参考文献4

二级参考文献27

  • 1JINNingyi,ZHANGHongyong,YINGefeng,ZHENGMin,LIUTong,JIANGWenzheng,LIZijian.Immunogenicity of recombinant fowl-pox virus co-expressing structural protein precursor P1-2A and proteinase 3C of FMDV[J].Chinese Science Bulletin,2004,49(8):823-827. 被引量:3
  • 2LIU Y, STACK S M, LAKKA S S, et al. Matrix localization of tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor (TFPI-2/MSPI) involves arginine-mediated ionic interactions with heparln and dermatan sulfate: heparin accelerates the activity of TFPI-2/MSPI toward plasmin[J].Archives of Biochemistry & Biophysics, 1999, 370 :112-118.
  • 3KONG D S, MA D, BAI H. Expression and acterization of the first kunitz domain of human tissue factor pathway inhibitor-2[J]. Biochem Biophys Res Commun, 2004, 324, 1179- 1185.
  • 4RAO C N, MOHANAM S, PUPPALA A, et al. Regulation of ProMMP-1 and ProMMP-3 activation by tissue factor pathway inhibitor-2 / matrix-associated serine protease inhibitor [J]. Biochem Biophys Res Commun, 1999, 255: 94-98.
  • 5NG P, PARKS R J, GRAHAM, F L, et al. A high efficiency Cre/loxP based system for construction of adenoviral vectors[J]. Hum Gene Ther, 1999, 10: 2667-2672.
  • 6NG P, PARKS R J, GRAHAM F L, et al. An enhanced system for construction of adenovlral vectors by the two piasmid rescue method[J]. Hum Gene Ther, 2000, 11:693-699.
  • 7NG P, CUMMINGS D T, GRAHAM F L, et al. The yeast recombinase FLP functions effectively in human cells for construction of adenovirus vectors[J]. Bio Techniques, 2000, 29: 524-528.
  • 8MICROBIX, AdMax. http://www, microbix, com/Public/ Default. aspx? I=56&n=AdMax.
  • 9KAWABATA K, SAKURAI F,KOIZUMI N, et al. Adenovirus vector mediated gene transfer into stem cells[J]. Mol Pharm, 2006, 3(2):95-103.
  • 10de FOUGEROLLES A R. Delivery vehicles for small interfering RNA invivo [J]. Hum Gene Ther, 2008, 19(2):125- 132.

共引文献3

同被引文献43

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部